Resources
Filter by Topic
- Publication
Authors: Nina Shah, Matthew Sussman, Concetta Crivera, Satish Valluri, Jennifer Benner & Sundar Jagannath Published: Clinical Drug Investigation Click here to view the article.
- Press Releases
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
- News & Events
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named IHD’s Data Science module as...
- Blogs
Q&A with Dr. Mark Friedman
- Publication
Podium and posters presented at Virtual ISPOR Europe 2020 November 16th - 19th.
- Blogs
By Matthew Sussman, MA
- News & Events
Virtual ISPOR Europe, November 16th - 19th
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
Linking Real-World Data is Like Making a Fine, Blended Wine
In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization